Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Kate.W
    Member
    • Aug 2012
    • 10

    #1

    Sequencing Single-end on DE to save money, good idea?

    Hi people!

    We assembled a de novo assembly using deep PE reads. Now we want to run biological replicates to analyse DE. Naively, I thought we should run he very same PE sequencing on those replicates, but I was advised by the people using illumina that, as my transcriptome is assembled and seems to be of good quality, I could go for SE sequencing. It'd save me a lot of money for same results. What would you think about that? Thanks!

    Kate
  • swbarnes2
    Senior Member
    • May 2008
    • 910

    #2
    They are probably right. If you aren't looking for alternate splicing, or SNPs, two paired reads on a transcript won't tell you more than one read.

    Comment

    • alexdobin
      Senior Member
      • Feb 2009
      • 161

      #3
      It does depend strongly of the biological questions you are trying to answer. If you want to analyze just the differential gene expression, the SE would be almost as good as PE - the main difference is that PE reads will contain fewer multi-mappers and will allow you to "resolve" better highly paralogous genes.

      On the other hand, if you want to quantify alternative isoforms, or assemble novel isoforms, PE reads give you much more power than single end. Many isoform quantification algorithms rely on "insert size distribution" which you can only get from PE reads.

      All in all, I think PE reads are more versatile than SE.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-13-2026, 09:56 AM
      0 responses
      22 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-09-2026, 11:14 AM
      0 responses
      28 views
      0 reactions
      Last Post SEQadmin2  
      Working...